2025 DIA China Concludes: MUST Delegates Spotlight GBA Clinical Research Innovation
The 2025 DIA China Annual Meeting was successfully concluded in Shanghai from May 22nd to May 25th, 2025, the meeting themed of “Converging Global Insight, Leading Healthcare Innovation” attracted over 3,000 professionals from regulatory agencies, academia, and industry.
2025 DIA China Annual Meeting
Non-Executive Director Creany Wong represented MUST-CTC introduced developments of innovative drug clinical trials in Macau during the standout session of“Current Situation and Prospect of Clinical Trial Ecology of Guangdong, HK and Macau Clinical Trials”
The 2025 DIA China Annual Meeting showcased the value of collaboration in pharmaceutical innovation. MUST-CTC will continue to play a pivotal role in facilitating GBA's emergence as a prominent global hub for pharmaceutical research and development.
